Cargando…

Comparison of the effects of recombinant human soluble thrombomodulin for systemic inflammatory response syndrome-associated coagulopathy with and without continuous hemodiafiltration

Detalles Bibliográficos
Autores principales:	Matsuo, SM, Ikeda, T, Ikeda, K, Ikeda, H, Suda, S, Hiramatsu, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066957/ http://dx.doi.org/10.1186/cc9703

Ejemplares similares

Efficacy of recombinant human soluble thrombomodulin in disseminated intravascular coagulation
por: Yasuda, T, et al.
Publicado: (2010)

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
por: Yamakawa, K, et al.
Publicado: (2014)

Clinical efficacy of recombinant human soluble thrombomodulin in patients with septic disseminated intravascular coagulation
por: Suzuki, Y, et al.
Publicado: (2013)

Pharmacokinetics of Standard- and Reduced-Dose Recombinant Human Soluble Thrombomodulin in Patients with Septic Disseminated Intravascular Coagulation during Continuous Hemodiafiltration
por: Watanabe, Eizo, et al.
Publicado: (2017)

New sepsis-related marker: endotoxin activity assay
por: Ikeda, T, et al.
Publicado: (2010)

Re-evaluation of direct hemoperfusion with polymyxin-B immobilized fiber for severe sepsis and septic shock
por: Matsuo, SM, et al.
Publicado: (2011)

Continuous hemodiafiltration for hypercytokinemia in tumor lysis syndrome
por: Nakamura, M, et al.
Publicado: (2005)

Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

Pharmacokinetics and pharmacodynamics of esomeprazole and ranitidine during continuous venovenous hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2013)

Systemic hemodynamic during continuous hemodiafiltration in patients with septic shock
por: Mouravev, O, et al.
Publicado: (2004)

Kinetics of TNF-α during continuous hemodiafiltration in patients with sepsis
por: Iakovleva, I, et al.
Publicado: (2004)

Changes in complement cascade during continuous hemodiafiltration (CHDF) in patients with sepsis
por: Ikeda, K, et al.
Publicado: (2002)

Role of early continuous venovenous hemodiafiltration in septic shock and multiorgan failure
por: Soliman, M, et al.
Publicado: (2010)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Pharmacokinetics of daptomycin in patients undergoing low-flow continuous venovenous hemodiafiltration
por: Ide, TI, et al.
Publicado: (2015)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study
por: Kato, Takahiro, et al.
Publicado: (2018)

Endotoxin adsorption method may affect serum procalcitonin
por: Ikeda, T, et al.
Publicado: (2008)

Effect of continuous hemodiafiltration (CHDF) on vascular endothelial cell function in sepsis patients
por: Ikeda, K, et al.
Publicado: (2003)

Effects of steroid therapies to severe streptococcal pneumoniae that required mechanical ventilation
por: Nagura, T, et al.
Publicado: (2013)

Can urinary 8-OHdG be a good indicator of vasospasm occurrence following subarachnoid hemorrhage?
por: Ikeda, K, et al.
Publicado: (2012)

Pharmacokinetics of ranitidine during hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2008)

Background factors in patients receiving immunoglobulin administration and changes in sepsis markers
por: Ikeda, T, et al.
Publicado: (2010)

Clinical effects of polymyxin B immobilised fiber with direct hemoperfusion for the patients of severe sepsis or septic shock caused by intra-abdominal infections
por: Ikeda, T, et al.
Publicado: (2009)

Amino acid concentrations in serum, urine and dialysate/ultrafiltrate solutions of continuous venovenous hemodiafiltration patients
por: Lee, JM, et al.
Publicado: (2012)

Impedance cardiography in the estimation of hemodynamic and fluid status of coma patients during continuous venovenous hemodiafiltration
por: De Nicola, A, et al.
Publicado: (2009)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2008)

Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated Coagulopathy
por: Levi, Marcel, et al.
Publicado: (2020)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

The effect of polymixin B immobilized on fibers and continuous veno-venous hemodiafiltration on tetrahydrobiopterine and NO metabolites in septic patients
por: Kakihana, Y, et al.
Publicado: (2006)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Usefulness of the endotoxin activity assay as a biomarker to assess severity in ICU patients
por: Noguchi, M, et al.
Publicado: (2014)

Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
por: Passos, RH, et al.
Publicado: (2006)

White blood cell counts have an impact on septic patient outcome followed by polymyxin-b immobilized fiber with direct hemoperfusion
por: Tanaka, H, et al.
Publicado: (2015)

Changes in procalcitonin and presepsin before and after immunoglobulin administration in septic patients
por: Ikeda, T, et al.
Publicado: (2015)

Elimination of linezolid in patients undergoing low-flow continuous venovenous haemodiafiltration
por: Ide, T, et al.
Publicado: (2012)

Control of intra-abdominal pressure in severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter and colloid fluid therapy
por: Matsuda, K, et al.
Publicado: (2005)

Coagulopathy of liver disease does not increase the filter life during continuous renal replacement therapy
por: Agarwal, B, et al.
Publicado: (2009)

Coagulofibrinolytic effects of recombinant soluble thrombomodulin in prolonged porcine cardiac arrest
por: Zhang, Boya, et al.
Publicado: (2023)

Effectiveness of continuous venovenous hemodiafiltration using a polymethylmethacrylate membrane hemofilter judging from a multiplex suspension array system in septic shock patients
por: Sakamoto, Y, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mtn0ji0ttsq9e7lu6q167ova3h